Subgroup analyses of patients with 2 or ≥ 3 exacerbations did not reach statistical significance, possibly due to limited power.
← all excerpts
Efficacy and safety of DPP-1 inhibitors in bronchiectasis: a GRADE-assessed meta-analysis of randomized controlled trials.
1
—
—